Brief: Adaptive Biotechnologies Signs Two Immune Receptor Licensing Deals With Pfizer
15/12/2025 14:29
Dec 15 (Reuters) - Adaptive Biotechnologies Corp ADPT.O: ADAPTIVE BIOTECHNOLOGIES ANNOUNCES TWO IMMUNE RECEPTOR LICENSING AGREEMENTS WITH PFIZER ADAPTIVE BIOTECHNOLOGIES CORP - PFIZER TO USE ADAPTIVE'S PLATFORM FOR RHEUMATOID ARTHRITIS ADAPTIVE BIOTECHNOLOGIES CORP - MAY RECEIVE UP TO $890 MILLION IN MILESTONES ADAPTIVE BIOTECHNOLOGIES CORP: SPECIFIC FINANCIAL TERMS OF AGREEMENT WILL NOT BE DISCLOSED Source text: ID:nGNX7KlcCt Further company coverage: ADPT.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Adaptive Biotechnologies
See all newsBrief: Adaptive Biotechnologies Corp - Issues $345 Million In 0% Convertible Senior Notes Due 2031 - SEC Filing
U.S. STOCKS ON THE MOVE-Jabil, BWX Technologies, Micron
U.S. STOCKS ON THE MOVE-Jabil, BWX Technologies, Micron
U.S. STOCKS ON THE MOVE-Intel, La-Z-Boy, CME
U.S. STOCKS ON THE MOVE-Intel, La-Z-Boy, AST SpaceMobile